[go: up one dir, main page]

DE69633391D1 - KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT - Google Patents

KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT

Info

Publication number
DE69633391D1
DE69633391D1 DE69633391T DE69633391T DE69633391D1 DE 69633391 D1 DE69633391 D1 DE 69633391D1 DE 69633391 T DE69633391 T DE 69633391T DE 69633391 T DE69633391 T DE 69633391T DE 69633391 D1 DE69633391 D1 DE 69633391D1
Authority
DE
Germany
Prior art keywords
alpha
msh
sequence
amino
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69633391T
Other languages
English (en)
Other versions
DE69633391T2 (de
Inventor
D Hinterland Lucien Dussourd
Anne-Marie Pinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Europeen de Biologie Cellulaire
Original Assignee
Institut Europeen de Biologie Cellulaire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Europeen de Biologie Cellulaire filed Critical Institut Europeen de Biologie Cellulaire
Publication of DE69633391D1 publication Critical patent/DE69633391D1/de
Application granted granted Critical
Publication of DE69633391T2 publication Critical patent/DE69633391T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69633391T 1995-06-12 1996-06-12 KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT Expired - Fee Related DE69633391T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9506909A FR2735131B1 (fr) 1995-06-12 1995-06-12 Conjugues d'msh avec un acide gras, leur procede de preparation et leur utilisation a titre de medicament
FR9506909 1995-06-12
PCT/FR1996/000890 WO1996041815A2 (fr) 1995-06-12 1996-06-12 CONJUGUES D'αMSH AVEC UN ACIDE GRAS, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT

Publications (2)

Publication Number Publication Date
DE69633391D1 true DE69633391D1 (de) 2004-10-21
DE69633391T2 DE69633391T2 (de) 2005-02-24

Family

ID=9479857

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633391T Expired - Fee Related DE69633391T2 (de) 1995-06-12 1996-06-12 KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT

Country Status (8)

Country Link
EP (1) EP0837881B1 (de)
JP (1) JPH11507661A (de)
AT (1) ATE276274T1 (de)
AU (1) AU6309496A (de)
DE (1) DE69633391T2 (de)
ES (1) ES2227597T3 (de)
FR (1) FR2735131B1 (de)
WO (1) WO1996041815A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1593384A3 (de) * 1999-06-29 2006-04-26 Palatin Technologies, Inc. Verbindungen zur Behandlung von sexuellen Funktionsstörungen
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
GB9930026D0 (en) * 1999-12-21 2000-02-09 Univ Sheffield Novel compounds of unsaturated fatty acids
US7166578B2 (en) 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US20040161443A1 (en) * 2001-04-17 2004-08-19 Macneil Sheila Vehicle
EP1827472A4 (de) 2004-12-06 2012-09-05 Univ California Verfahren zur verbesserung der struktur und funktion von arteriolen
WO2009014105A1 (ja) * 2007-07-20 2009-01-29 Yamada Apiculture Center, Inc. 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
JP5715104B2 (ja) * 2012-09-27 2015-05-07 アブビー インコーポレイティド 治療的に活性なα−ＭＳＨアナログ
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389950A1 (de) * 1989-03-23 1990-10-03 Lion Corporation Inhibitor des melanocytenstimulierenden Hormons und dieses enthaltendes, äusserlich anwendbares Präparat
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .

Also Published As

Publication number Publication date
AU6309496A (en) 1997-01-09
ES2227597T3 (es) 2005-04-01
WO1996041815A2 (fr) 1996-12-27
ATE276274T1 (de) 2004-10-15
EP0837881A2 (de) 1998-04-29
JPH11507661A (ja) 1999-07-06
FR2735131A1 (fr) 1996-12-13
DE69633391T2 (de) 2005-02-24
WO1996041815A3 (fr) 1997-01-30
FR2735131B1 (fr) 1997-08-22
EP0837881B1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
DE69633391D1 (de) KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT
CO4520232A1 (es) Conjugados de interferon-polimero y proceso para preparar el mismo
DE69423911D1 (de) Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
IE791292L (en) Poly-(carbonate-urethanes).
DE59409616D1 (de) Lipopeptide aus Actinoplanes sp. mit pharmakologischer Wirkung, Verfahren zu ihrer Herstellung und Verwendung derselben
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
ATE145649T1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon
IT1277596B1 (it) Composti macromolecolari di tipo dendrimerico
DE3885928D1 (de) Verfahren zur Herstellung von parenteral verabreichbaren Chinoloncarbonsäuren.
IT1249732B (it) Oligonucleotidi antisenso.
ITMI921925A1 (it) Processo per preparare gli acidi biliari coniugati con la taurina
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
ES8704754A1 (es) Un procedimiento para la preparacion de composiciones de un acido amino hidrocarbil sulfonico n-acilado o una sal del mismo.
IT1254996B (it) Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
EP0366041A3 (de) Imido-percarbonsäuren
ATE27464T1 (de) Herstellung von ursodeoxycholsaeurekonjugaten.
FR2491922B1 (de)
ES2058047T3 (es) Resolucion de acido arilalcanoico.
ATE32229T1 (de) Carboxylmodifizierte vinylesterurethan-harze, ihre anwendung und verwertung.
KR850000468A (ko) 사이클릭 펩타이드의 제조방법
KR840002346A (ko) 펩타이드의 제조방법
ATE224373T1 (de) Verfahren zur herstellung von alkylimidazolidinon(meth)acrylaten
DE69203142D1 (de) Von l-Glutaminsäure abgeleitete Süssungsmittel, Verfahren zu ihrer Herstellung.
AU544236B2 (en) Amidines
IT1240325B (it) Derivati insaturi di acidi biliari, loro preparazione e composizione farmaceutiche che li contengono

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee